ProKidney Corp.
Statements
Cash Flow
All figures as a percentage of revenue in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | -564.8% | – | – | – | -31,803.9% | -12,866.1% | -14,215.4% | -12,256.2% | -14,450.2% | -18,444.2% | -26,916.0% | -17,257.6% | |
| – | 25.5% | – | – | – | 2,071.1% | 695.7% | 662.9% | 644.2% | 816.4% | 733.6% | 1,118.7% | 803.3% | |
| – | -141.7% | – | – | – | 9,142.1% | 2,789.6% | 2,959.7% | 3,076.5% | 2,534.7% | 2,188.1% | 3,729.3% | 2,801.7% | |
| – | 86.9% | – | – | – | 23,098.7% | 483.9% | -855.7% | 600.0% | 336.4% | -2,324.3% | 5,140.7% | 552.2% | |
| – | 35.0% | – | – | – | 33,564.5% | 493.5% | 1,408.1% | 2,394.9% | 2,556.4% | 1,674.8% | 2,555.3% | 2,269.8% | |
| – | -2,132.7% | – | – | – | 19,842.1% | 12,299.6% | 8,400.5% | 13,372.4% | 12,485.8% | 15,410.2% | 8,537.3% | 12,804.9% | |
| – | -211.4% | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | -18.4% | -5.2% | -6.3% | 2.3% | -2.2% | -1.3% | -3.3% | -1.0% | |
| – | -211.7% | – | – | – | 161.8% | -5.2% | -6.3% | 3,668.7% | 7,837.3% | 95.1% | 360.7% | 3,221.4% | |
| – | -2,909.2% | – | – | – | -11,800.0% | -571.7% | -5,821.3% | 4,784.8% | 5,872.9% | -2,938.9% | -18,018.0% | -1,231.3% | |
| – | -599.8% | – | – | – | -65,368.4% | -13,359.6% | -15,623.5% | -14,651.2% | -17,006.7% | -20,119.0% | -29,471.3% | -19,527.4% |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: October 5, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.